Ensaios clínicos de Sobrepeso em Maryland
37 estudos para Sobrepeso estão buscando participantes em locais em Maryland.
Cidades em Maryland
Texto oficial do estudo (Inglês)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Barry J. Reiner, MD LLC, Baltimore
RecrutandoFase 3
Idades de 8 a 18 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07253285A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Centennial Medical Group, Columbia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07794579Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
- National Institutes of Health Clinical Center, Bethesda
RecrutandoFase 2Voluntários saudáveis bem-vindos
Idades de 18 a 60 · Mulheres · Atualizado em 28 de set. de 2026 · NCT03407079A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07595549Physical and Behavioral Traits of Overweight and Obese Adults
- National Institutes of Health Clinical Center, Bethesda
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 18 a 100 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT00428987A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Beltsville
- Research Site, Oxon Hill
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Johns Hopkins Children's Center, Baltimore
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Capital Digestive Care - Chevy Chase, Chevy Chase
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MedStar Good Samaritan Hospital, Baltimore
- MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- MD Medical Research, Oxon Hill
- Velocity Clinical Research - Rockville, Rockville
RecrutandoFase 3
Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Centennial Medical Group, Columbia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Bowie, Bowie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Centennial Medical Group, Columbia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Beltsville
- Research Site, Lanham
- Research Site, Oxon Hill
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
- National Institutes of Health Clinical Center, Bethesda
Recrutando
Idades de 18 a 65 · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06044935Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 12 a 25 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06730113A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Brooklyn
RecrutandoFase 1Voluntários saudáveis bem-vindos
Idades de 35 a 75 · Mulheres · Atualizado em 17 de set. de 2026 · NCT07013643A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Bowie
- AURORA-1 Clinical Site, Rockville
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bowie
- AURORA-2 Clinical Site, Rockville
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centennial Medical Group, Columbia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Baltimore VA Medical Center, Baltimore
- Johns Hopkins University School of Nursing, Baltimore
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Silver Spring
RecrutandoFase 3Voluntários saudáveis bem-vindos
Idades de 18 a 79 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07654374A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Intl - EPCU-Baltimore, Baltimore
RecrutandoFase 1
Idades de 18 a 55 · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07566390Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- Johns Hopkins University, Baltimore
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06847399A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Dermatology and Skin Cancer Specialists, LLC, Rockville
RecrutandoFase 4
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06857942Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Columbia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284875Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Annapolis
- Kailera Clinical Site, Columbia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Silver Spring
RecrutandoFase 3
Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
- National Institutes of Health Clinical Center, Bethesda
Recrutando
Idades de 18 a 50 · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06325722Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
- Johns Hopkins School of Nursing, Baltimore
Recrutando
Idades 18 e acima · Mulheres · Atualizado em 8 de jun. de 2026 · NCT05619705A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Parexel International-EPCU Baltimore, Baltimore
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
Idades de 18 a 60 · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT06842186Night Owl Metabolism
- Johns Hopkins School of Medicine, Baltimore
RecrutandoVoluntários saudáveis bem-vindos
Idades de 18 a 23 · Todos os sexos · Atualizado em 11 de mai. de 2026 · NCT06507722Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity
- Johns Hopkins University, Baltimore
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 16 de mar. de 2026 · NCT07396805Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Johns Hopkins University, Baltimore
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jan. de 2026 · NCT06273072Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
- Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Recrutando
Todas as idades · Mulheres · Atualizado em 23 de dez. de 2025 · NCT07032545Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
- Pharmaron CPC, Inc, Baltimore
RecrutandoFase 1Voluntários saudáveis bem-vindos
Idades de 18 a 55 · Todos os sexos · Atualizado em 6 de nov. de 2025 · NCT07224399Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.